FDA Recall United States Terminated Historical recordClass II
Continental Mills (Corporate Office)
- Product
- Item # 721-1000, Krusteaz Belgian Waffle Mix. Product is sh…
- Reason
- foreign materials
- Published
- April 20, 2022
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,113
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,793
Class I recallsReasonable probability of serious health consequences24,343
Class II recallsTemporary or medically reversible health consequences2,887
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/whole-foods-market-issues-allergy-alert-undeclared-egg-cabricharme-cheesePublished September 11, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,343 |
| Class I | 9,793 |
| Class III | 2,887 |
| Not Yet Classified | 1 |
| Class | Recalls |
|---|---|
| Class II | 24,343 |
| Class I | 9,793 |
| Class III | 2,887 |
| Not Yet Classified | 1 |
FDA Recall United States Terminated Historical recordClass II
Continental Mills (Corporate Office)
- Product
- Item # 743-0278, IHOP Pancake. Product is shelf stable and…
- Reason
- foreign materials
- Published
- April 20, 2022
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Continental Mills (Corporate Office)
- Product
- Item # 731-0120, Krusteaz Pro Buttermilk Pancake Mix. Produ…
- Reason
- foreign materials
- Published
- April 20, 2022
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Continental Mills (Corporate Office)
- Product
- Item # 721-0200, Krusteaz Buttermilk Pancake Mix. Product i…
- Reason
- foreign materials
- Published
- April 20, 2022
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Continental Mills (Corporate Office)
- Product
- Item # 714-5000, Great Value Buttermilk Pancake & Waffle Mix…
- Reason
- foreign materials
- Published
- April 20, 2022
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Continental Mills (Corporate Office)
- Product
- Item # 714-0706, Kroger Buttermilk Pancake & Waffle Mix. Pr…
- Reason
- foreign materials
- Published
- April 20, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass III
Cequa (cyclosporine ophthalmic solution) 0.09%, packaged in 6 pouches x 10 single-use vials (0.25 mL each) per box, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, ZI de la Guerie, F-50211 Coutances Cedex, France, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-506-96
- Reason
- Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass I
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.
- Reason
- Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass I
SYMJEPI (epinephrine injection, USP) 0.3 mg, (0.3 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-130-02
- Reason
- Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass III
Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured for: Macleods Pharma USA, Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., BAddi, HImchal Pradesh, INDIA, NDC 33342-107-07.
- Reason
- FAILED CONTENT UNIFORMITY SPECIFICATIONS
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Accuretic (quinapril HCl/hydrochlorothiazide) tablets, 20 mg/12.5 mg*, 90 Tablets, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY. NY 10017, Made in Germany, NDC 0071-5212-23 .
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
quinapril HCl/hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0223-1
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-0220-1
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
quinapril and hydrochlorothiazide tablets, 20 mg/25 mg*, 90 Tablets bottles, Rx Only, Distributed by: Greenstone, LLC, Peapack, NJ, 07977, Made in Germany, NDC 59762-5225-9
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/25 mg, 90 tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0223-23.
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 20 mg/12.5 mg, 90 tablets bottles, Rx Only Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0220-23.
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Accuretic (quinapril HCl/hydrochlorothiazide) Tablets 10 mg/12.5 mg 90 tablets bottle, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-0222-23
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Accuretic (quinapril HCl/hydrochlorothiazide) Tablets, 10 mg/12.5 mg*, 90 Tablets bottles, Rx Only, Distributed by: Parke-Davis, Division of Pfizer Inc, NY, NY 10017, Made in Germany, NDC 0071-3112-23.
- Reason
- CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., Princeton, NJ 08540 NDC 0185-0022-01.
- Reason
- CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.
- Published
- April 13, 2022
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass III
Methylprednisolone Tablets, USP 4mg, 100-count bottle, Rx Only, Manufactured by: Jubliant Cadista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-001-06
- Reason
- Subpotent
- Published
- April 13, 2022
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
